Sonoma Pharmaceuticals (SNOA) Operating Income: 2010-2012
Historic Operating Income for Sonoma Pharmaceuticals (SNOA) over the last 3 years, with Dec 2012 value amounting to -$680,000.
- Sonoma Pharmaceuticals' Operating Income rose 71.11% to -$680,000 in Q4 2012 from the same period last year, while for Dec 2012 it was -$3.5 million, marking a year-over-year increase of 45.88%. This contributed to the annual value of -$6.5 million for FY2012, which is 13.83% up from last year.
- According to the latest figures from Q4 2012, Sonoma Pharmaceuticals' Operating Income is -$680,000, which was up 16.77% from -$817,000 recorded in Q3 2012.
- Sonoma Pharmaceuticals' 5-year Operating Income high stood at -$495,000 for Q2 2012, and its period low was -$2.4 million during Q2 2010.
- Over the past 3 years, Sonoma Pharmaceuticals' median Operating Income value was -$1.5 million (recorded in 2012), while the average stood at -$1.5 million.
- Within the past 5 years, the most significant YoY rise in Sonoma Pharmaceuticals' Operating Income was 75.47% (2012), while the steepest drop was 29.68% (2012).
- Quarterly analysis of 3 years shows Sonoma Pharmaceuticals' Operating Income stood at -$2.1 million in 2010, then fell by 13.28% to -$2.4 million in 2011, then surged by 71.11% to -$680,000 in 2012.
- Its last three reported values are -$680,000 in Q4 2012, -$817,000 for Q3 2012, and -$495,000 during Q2 2012.